The role of FKBP5 in cancer aetiology and chemoresistance
2011

The role of FKBP5 in cancer aetiology and chemoresistance

Sample size: 300 publication Evidence: moderate

Author Information

Author(s): Li L, Lou Z, Wang L

Primary Institution: Mayo Clinic

Hypothesis

FKBP5 plays a significant role in cancer aetiology and response to antineoplastic therapy.

Conclusion

FKBP5 has altered expression levels in many different tumors and may serve as a biomarker for chemoradiosensitivity.

Supporting Evidence

  • FKBP5 is involved in multiple signaling pathways that affect cancer growth and treatment response.
  • Altered FKBP5 expression levels correlate with sensitivity to chemotherapy agents like gemcitabine.
  • FKBP5 may function as a biomarker for predicting responses to cancer treatments.

Takeaway

FKBP5 is a protein that can help doctors understand how cancer cells respond to treatment, and its levels can change in different types of cancer.

Methodology

This review summarizes recent findings on FKBP5's role in cancer and its mechanisms of action.

Limitations

The role of FKBP5 in tumorigenesis remains controversial and may vary by tissue type.

Participant Demographics

The study references findings from lymphoblastoid cell lines from 300 individuals.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606014

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication